High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

The Hidden Social Health Risk Quietly Harming Your Patients

As awareness on the negative effects of loneliness grows, this overlooked social health factor may be silently worsening outcomes for nearly one third of adults.

Improve Sleep by Rethinking Drugs in Older Patients

Screen more aggressively for sleep apnea, start with behavioral treatments for insomnia, and limit the use of higher-risk sleep medications in older adults.

Electronic Nudges Speed up Heart Valve Care

Automated electronic clinician notification alerts enhance the timely evaluation and treatment of clinically significant aortic stenosis and mitral regurgitation.

SGLT-2 Drugs May Cut Renal Injury Risk in Hospital Setting

Use of SGLT-2 inhibitor therapy at hospital admission is associated with a 32% reduced risk for acute kidney injury in hospitalised patients, a Dutch study finds.

Ancestry May Shape Cardiac Risk in Black Soccer Players

In a large screening study, Black soccer players of West African ancestry had higher rates of serious cardiac conditions than other players, with risk varying substantially by ancestral origin.

HCM Linked to Higher Risk for Out-of-Hospital Cardiac Arrest

Hypertrophic cardiomyopathy is associated with an increased long term risk for out of hospital cardiac arrest, especially if diagnosed later in life or with heart failure.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Todays Updates

T-DXd Reduces Residual Disease in Early Breast Cancer

Neoadjuvant trastuzumab deruxtecan combination therapy reduces the residual cancer burden in high-risk early breast cancer, even if a pathologic complete response is not achieved, shows analysis.

Latest News

As awareness on the negative effects of loneliness grows, this overlooked social health factor may be silently worsening outcomes for nearly one third of adults.

Screen more aggressively for sleep apnea, start with behavioral treatments for insomnia, and limit the use of higher-risk sleep medications in older adults.

Automated electronic clinician notification alerts enhance the timely evaluation and treatment of clinically significant aortic stenosis and mitral regurgitation.

Use of SGLT-2 inhibitor therapy at hospital admission is associated with a 32% reduced risk for acute kidney injury in hospitalised patients, a Dutch study finds.

In a large screening study, Black soccer players of West African ancestry had higher rates of serious cardiac conditions than other players, with risk varying substantially by ancestral origin.

Hypertrophic cardiomyopathy is associated with an increased long term risk for out of hospital cardiac arrest, especially if diagnosed later in life or with heart failure.

News All Time

Postpartum Antihypertensive Use Flags Future Heart Risk

Early postpartum antihypertensive treatment may signal long-term cardiovascular risk in women with hypertensive disorders of pregnancy.

Key Drivers of Ventricular Dysfunction After Pacing

Patients receiving right ventricular pacing — particularly those with a history of ischaemic heart disease and a high pacing burden — often develop left ventricular systolic dysfunction.

Cardiac MRI Gains Central Role in Pericarditis Diagnosis

Cardiac MRI now plays a pivotal role in confirming pericarditis and myocarditis while reducing reliance on biopsy.

Respiratory Diseases Become Biggest Killer Among Men With RA

Respiratory diseases overtook cardiovascular disease in a 10-year study of men in the southwest of England.

Frailty, Not Age, Drives Risk With SGLT2, GLP-1 Meds

Higher risk for genital infections with SGLT2 inhibitors were observed in frail patients among older adults.

Trial: Subclinical AF Burden Not Enough to Guide OAC

The burden of subclinical atrial fibrillation didn’t predict stroke or other embolic events or the impact of direct oral anticoagulation in a NOAH-AFNET 6 substudy.

CVD, ICU Stay Tied to Klebsiella Infection Post-Transplant

Klebsiella infections are common among solid organ transplant recipients older than 50; a history of cardiovascular disease and posttransplant ICU stay of 3 or more days may each raise this risk.

Two Global Forces Are Colliding in Europe’s Waiting Rooms

From sickle cell crises to kidney injury, changing patient profiles and rising temperatures are creating new clinical blind spots.

Pancreatitis Recurrence Risk Lower With GLP-1 Continuation

Contrary to regulatory warnings, research shows no link between the continuation of GLP-1s following acute pancreatitis and an increased risk for recurrence.

Med Op-Ed: Trusty Nurses, Hawthorne Effect on BP, and More

Why nurse scientists could play a key role in public health messaging, how to make sense of noisy blood pressure readings, and how much time doctors spend on mandatory training modules.

Heart Failure Hospitalizations Rose in Younger Patients

The rates of hospitalizations for heart failure rise among patients younger than 65 years and decrease in those aged 65 years or older between 2010 and 2022, a new study finds.

PFA Bests Meds as First-Line Treatment for Persistent AF

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

Scientists Rethink How Much Lifespan Is in Our Control

Research upending long-held estimates of genetic influence on lifespan could relieve the pressure to get all the lifestyle factors right.

Fibrosis May Predict Outcomes in Aortic Stenosis

In asymptomatic patients with severe aortic stenosis, higher midwall fibrosis burden is linked to a higher risk for adverse outcomes.

CKM Syndrome Associated With Major Risk for Cancer

Patients with cardiovascular-kidney-metabolic syndrome, especially those in the advanced stages at baseline, show a significant risk for incident cancer, stressing the need for risk assessment.

Can Radiation Reduce Refractory Ventricular Tachycardia?

Stereotactic arrhythmia radioablation reduces sustained ventricular tachycardia episodes and defibrillator shocks in patients with treatment-refractory disease, without treatment related deaths.

Recommended News For You

Research discovery halts childhood brain tumor before it forms

Understudied mental health challenges among caregivers of cancer patients: A call for targeted support

Why Encouragement May Not Improve Motivation in Depression

Do Anatomy Atlases Reflect Social Inequalities?

If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version

Adding cell-based vaccine to liver cancer therapy can slow cancer progression

Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia

Recommended Articles For You

How Bispecific Antibodies are Redefining Medical Oncology in the US - A 2025 Review 

Unraveling the Complexities of Embryonal Carcinoma: A New Hope for Treatment 

Transfusing the Future: Exploring the Possibilities of Blood Transfusions 

Gut microbiota in curing cancer 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

An ancient signaling pathway and 20 years of research offer hope for rare cancer

2.

Biocomputer From Human Neurons Plays Doom, Raises Ethics

3.

Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer

4.

NIH research cuts leave cancer patient facing hard choice

5.

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

1.

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision

2.

What is Hemorrhagic Cystitis and How to Manage its Symptoms

3.

Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment

4.

From Bench to Bedside: The New Era of Lymphoma Treatment and Education

5.

All You Need To Know About Partial Thromboplastin Time (PTT) Test

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion

2.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

3.

Navigating the Complexities of Ph Negative ALL - Part XII

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot